July 29, 2003

Takeda Chemical Industries, Ltd.

Takeda to Increase Capital of Takeda America Holdings, Inc.

OSAKA, JAPAN, July 29, 2003---Takeda Chemical Industries, Ltd. ("Takeda") announced today that it increased the capital of Takeda America Holdings, Inc. ("TAH"), its wholly owned holding company, by US$2.6 billion effective today.

For Takeda, the importance of the U.S. pharmaceutical market, that is the largest in the world, is increasing remarkably as the recent business expansion in the U.S. is a primary contributor to the growth of the company. The capital increase of TAH this time will enable Takeda to meet flexibly the needs of fund for further business expansion in the U.S. when such needs arise. The enhancement of the U.S. operation is one of the key agenda for Takeda.

In addition, the transfer of certain fund from Japan to the U.S. will be beneficial for Takeda on a consolidated basis because of the difference of interest rate in each country.

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the industry's leaders worldwide, Takeda is committed to strive toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

[Overview of Increase Capital]

	Increase amount	US$2.6 billion
	Capital after increase	US$2,827,256,716
	Effective date	July 29, 2003
	Paid-in form	Cash

[Outline of Takeda America Holdings, Inc.]

	Company name	Takeda America Holdings, Inc.
	Representative	Kenjiro Morimoto
	Location	555 Madison Avenue, New York, NY, USA
	Established	July 1, 2001
	Business description	Holding company for Takedafs pharmaceutical business in the U.S.
		and fund management based on the dividend received
	Fiscal year	January 1 to December 31

# # #